- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Fastenal may never fascinate investors with exciting products or technologies, but its consistency makes it a strong candidate to consider in a covered option strategy.
Tired and lowly regarded stocks may hold the key to withstanding potential market decline.